Evidence map›Paper›PMID 34592886›Full record

ArticleBioengineered2021

Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.

Xingli Zhuo, Lan Chen, Zongwei Lai, Jiansheng Liu, Shengjun Li, Ahu Hu, Yuansheng Lin

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Xingli ZhuoDepartment of emergency and critical care medicine, The Affiliated Suzhou Science&Technology Town Hospital of Nanjing Medical University, Suzhou, China.
Lan ChenDepartment of Respiratory Medicine, Gannan Medical University, Ganzhou, China.
Zongwei LaiDepartment of Respiratory Medicine, Gannan Medical University, Ganzhou, China.
Jiansheng LiuDepartment of Respiratory Medicine, Ganzhou People's Hospital, Ganzhou, China.
Shengjun LiDepartment of emergency and critical care medicine, The Affiliated Suzhou Science&Technology Town Hospital of Nanjing Medical University, Suzhou, China.
Ahu HuDepartment of emergency and critical care medicine, The Affiliated Suzhou Science&Technology Town Hospital of Nanjing Medical University, Suzhou, China.
Yuansheng LinDepartment of emergency and critical care medicine, The Affiliated Suzhou Science&Technology Town Hospital of Nanjing Medical University, Suzhou, China.ORCID 0000-0001-9783-9109
Nanjing Medical University · CNGannan Medical University · CNGanzhou People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The protein phosphatase 1 regulatory subunit 3 G (PPP1R3G) participates in many tumor biological processes; however, its effects on lung adenocarcinoma (LUAD) have not been clarified. Therefore, this study aimed to explore the correlation between PPP1R3G and the prognosis and immune invasion of LUAD. We evaluated the relationship between PPP1R3G and LUAD using a wide range of databases and analysis tools, including UALCAN, TIMER, miRDB, The Human Protein Atlas and the MethSurv database. First, we explored the mRNA and protein expression levels of PPP1R3G in LUAD, and results were validated using real-time PCR. Next, we explored the relationship between PPP1R3G expression and clinical features. Finally, Kaplan-Meier curves and Cox regression were employed to investigate the prognostic significance of PPP1R3G in LUAD. In addition, we explored the relationship between the expression of PPP1R3G and immune infiltration using the TIMER database. We analyzed the relationship between PPP1R3G and methylation using MethSurv database. Results showed that PPP1R3G expression in LUAD tissues was higher than that in normal tissues, and high expression was suggestive of a poor prognosis. Moreover, PPP1R3G expression was positively correlated with the immune infiltration of CD4 + T cells, macrophages, neutrophils, and dendritic cells. PPP1R3G copy number variations also demonstrated remarkable associations with the levels of B cells, CD4 + T cells, macrophages, neutrophils, and dendritic cells. Finally, a PPP1R3G-associated regulatory network was constructed. Overall, PPP1R3G might be a poor prognostic biomarker for LUAD and is associated with tumor immune cell infiltration.

Indexed as

DNA MethylationUp-RegulationAdenocarcinoma of LungAgedAnimalsBiomarkers, TumorCell Line, TumorEpigenesis, GeneticFemaleGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansKaplan-Meier EstimateLung NeoplasmsMaleMiceBiomarkers, TumorPPP1R3G protein, humanProtein Phosphatase 1bioinformaticsimmunelung adenocarcinomaPPP1R3Gprognosis

Identifiers

PMID34592886
PMCPMC8806970
OpenAlexW3204336261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.